Table 6. Predictive factors for overall survival by univariate and multivariate analysis in patients underwent heterochronous resection.
Characteristics | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Age | |||||
>65 vs. ≤65 years | 0.357 (0.083–1.536) | 0.166 | 1.121 (0.200–6.285) | 0.896 | |
Gender | |||||
Male vs. female | 0.738 (0.345–1.580) | 0.435 | 0.808 (0.309–2.116) | 0.664 | |
BMI | |||||
≥24 vs. <24 kg/m2 | 1.655 (0.782–3.502) | 0.188 | 2.656 (1.066–6.618) | 0.036b | |
Primary tumor gradea | |||||
G3 vs. G1–2 | 2.321 (1.010–5.332) | 0.047b | 5.400 (1.675–17.414) | 0.005b | |
Primary tumor location | |||||
Right-sided vs. left-sided | 1.388 (0.324–5.940) | 0.658 | 1.614 (0.359–7.255) | 0.532 | |
T-stagea | |||||
pT4 vs. pT1–3 | 1.304 (0.612–2.777) | 0.491 | 1.440 (0.537–3.862) | 0.468 | |
N-stagea | |||||
pN1–2 vs. pN0 | 1.273 (0.588–2.755) | 0.540 | 0.553 (0.195–1.567) | 0.265 | |
Preoperative chemotherapy before liver resection | |||||
Yes vs. no | 1.289 (0.614–2.703) | 0.502 | 4.167 (1.362–12.743) | 0.012b | |
Preoperative chemotherapy before liver resection | |||||
Yes vs. no | 1.646 (0.717–3.779) | 0.240 | 3.280 (1.088–9.886) | 0.035b | |
Immune score LM | |||||
High vs. low | 0.438 (0.200–0.959) | 0.039b | 0.340 (0.130–0.889) | 0.028b | |
Immune score PT | |||||
High vs. low | 0.766 (0.360–1.628) | 0.488 | 0.502 (0.157–1.600) | 0.244 |
a, according to Union for International Cancer Control (UICC) staging system (7th edition); b, P value <0.05 was defined as statistically significant. BMI, body mass index; LM, liver metastases; PT, primary tumor.